LEDERLE AND P&G TO CO-PROMOTE ZIAC, FIRST ANTIHYPERTENSIVE DEVELOPED SPECIFICALLY TO ADDRESS DOSE-RELATED SIDE EFFECTS

Source :: PR Newswire. November 22, 1993, 1122NY003
Publication Year :: 1993
Abstract: WAYNE, N.J., and CINCINNATI, Nov. 22 /PRNewswire/ -- Lederle Laboratories, a division of American Cyanamid Company (NYSE: ACY), and Procter & Gamble Pharmaceuticals (NYSE: PG) today announced a major agreement [...]

Subjects :: American Cyanamid Co. Lederle Laboratories Div. -- Product introduction -- Marketing -- Contracts
Procter & Gamble Pharmaceuticals -- Contracts -- Product introduction -- Marketing
Cardiovascular agents -- Product introduction
Drugs -- Product introduction
Hypotension -- Product introduction
Antihypertensive drugs -- Marketing
Pharmaceutical industry -- Contracts -- Product introduction
Company marketing practices
Contract agreement
Business
News, opinion and commentary

Tools